• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狂犬病病毒糖蛋白作为炭疽保护性抗原的载体

Rabies virus glycoprotein as a carrier for anthrax protective antigen.

作者信息

Smith Mary Ellen, Koser Martin, Xiao Sa, Siler Catherine, McGettigan James P, Calkins Catherine, Pomerantz Roger J, Dietzschold Bernhard, Schnell Matthias J

机构信息

Department of Microbiology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

Virology. 2006 Sep 30;353(2):344-56. doi: 10.1016/j.virol.2006.05.010. Epub 2006 Jul 3.

DOI:10.1016/j.virol.2006.05.010
PMID:16820183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1576297/
Abstract

Live viral vectors expressing foreign antigens have shown great promise as vaccines against viral diseases. However, safety concerns remain a major problem regarding the use of even highly attenuated viral vectors. Using the rabies virus (RV) envelope protein as a carrier molecule, we show here that inactivated RV particles can be utilized to present Bacillus anthracis protective antigen (PA) domain-4 in the viral membrane. In addition to the RV glycoprotein (G) transmembrane and cytoplasmic domains, a portion of the RV G ectodomain was required to express the chimeric RV G anthrax PA on the cell surface. The novel antigen was also efficiently incorporated into RV virions. Mice immunized with the inactivated recombinant RV virions exhibited seroconversion against both RV G and anthrax PA, and a second inoculation greatly increased these responses. These data demonstrate that a viral envelope protein can carry a bacterial protein and that a viral carrier can display whole polypeptides compared to the limited epitope presentation of previous viral systems.

摘要

表达外源抗原的活病毒载体作为抗病毒疾病疫苗已显示出巨大潜力。然而,即使是使用高度减毒的病毒载体,安全问题仍是一个主要问题。我们在此表明,利用狂犬病毒(RV)包膜蛋白作为载体分子,灭活的RV颗粒可用于在病毒膜上呈递炭疽芽孢杆菌保护性抗原(PA)结构域4。除了RV糖蛋白(G)的跨膜和胞质结构域外,还需要一部分RV G胞外结构域才能在细胞表面表达嵌合RV G炭疽PA。这种新型抗原也能有效地整合到RV病毒粒子中。用灭活的重组RV病毒粒子免疫的小鼠表现出针对RV G和炭疽PA的血清转化,二次接种大大增强了这些反应。这些数据表明,病毒包膜蛋白可以携带细菌蛋白,与以前病毒系统有限的表位呈递相比,病毒载体可以展示完整的多肽。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3ebc8ee0c589/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/2f91573522ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/c00f807974cc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/237792961534/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/7fe5794e3516/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3065e1f40493/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/0e2d43b6fcaf/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3281a079300c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3ebc8ee0c589/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/2f91573522ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/c00f807974cc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/237792961534/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/7fe5794e3516/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3065e1f40493/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/0e2d43b6fcaf/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3281a079300c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c5/7111871/3ebc8ee0c589/gr8.jpg

相似文献

1
Rabies virus glycoprotein as a carrier for anthrax protective antigen.狂犬病病毒糖蛋白作为炭疽保护性抗原的载体
Virology. 2006 Sep 30;353(2):344-56. doi: 10.1016/j.virol.2006.05.010. Epub 2006 Jul 3.
2
Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.使用表达保护性抗原的病毒复制子载体增强炭疽疫苗效果。
Immunol Lett. 2015 Feb;163(2):206-13. doi: 10.1016/j.imlet.2014.07.012. Epub 2014 Aug 4.
3
Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.生成新型炭疽杆菌嵌合 PALFn 抗原及其在小鼠模型中的免疫特性分析。
Appl Microbiol Biotechnol. 2016 Oct;100(19):8439-51. doi: 10.1007/s00253-016-7684-4. Epub 2016 Jun 30.
4
Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.口服表达炭疽芽孢杆菌保护性抗原的基于肠炎沙门氏菌的疫苗可提供针对气溶胶化炭疽芽孢杆菌的保护。
Infect Immun. 2007 Apr;75(4):1827-34. doi: 10.1128/IAI.01242-06. Epub 2006 Dec 4.
5
Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.含有炭疽芽孢杆菌保护性抗原大片段的嵌合流感病毒血凝素蛋白:蛋白特性、掺入感染性流感病毒以及抗原性
J Virol. 2005 Aug;79(15):10003-12. doi: 10.1128/JVI.79.15.10003-10012.2005.
6
A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.叶绿体中表达的植物源性保护性抗原 [PA(dIV)] 疫苗可在小鼠中诱导针对炭疽病的保护性免疫。
Vaccine. 2011 Jun 15;29(27):4521-33. doi: 10.1016/j.vaccine.2011.03.082. Epub 2011 Apr 17.
7
A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice.一种表达修饰狂犬病病毒糖蛋白的重组犬瘟热病毒可在小鼠体内诱导免疫反应。
Virus Genes. 2015 Jun;50(3):434-41. doi: 10.1007/s11262-015-1169-x. Epub 2015 Mar 13.
8
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.用重组的、荧光假单胞菌表达的炭疽芽孢杆菌衍生保护性抗原突变体对兔子进行免疫可使其免受炭疽感染。
PLoS One. 2015 Jul 24;10(7):e0130952. doi: 10.1371/journal.pone.0130952. eCollection 2015.
9
Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.DNA疫苗接种后小鼠对炭疽芽孢杆菌STI孢子攻击的保护作用。
Int J Med Microbiol. 2004 Jul;294(1):35-44. doi: 10.1016/j.ijmm.2003.12.002.
10
Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.利用流感病毒载体诱导针对炭疽保护性抗原的中和抗体反应:对不同免疫系统启动途径的影响。
J Virol. 2010 Aug;84(16):8300-7. doi: 10.1128/JVI.00183-10. Epub 2010 May 26.

引用本文的文献

1
Commentary: Inactivated rabies virus vectored MERS-Coronavirus vaccine induces protective immunity in mice, camels, and alpacas.评论:灭活狂犬病病毒载体中东呼吸综合征冠状病毒疫苗在小鼠、骆驼和羊驼中诱导产生保护性免疫。
Front Immunol. 2025 Mar 4;16:1549481. doi: 10.3389/fimmu.2025.1549481. eCollection 2025.
2
Rabies virus as vector for development of vaccine: pros and cons.狂犬病病毒作为疫苗开发载体:利弊分析
Front Vet Sci. 2024 Sep 25;11:1475431. doi: 10.3389/fvets.2024.1475431. eCollection 2024.
3
The Development of a Rabies Virus-Vectored Vaccine against , Targeting BBI39.

本文引用的文献

1
Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.含有炭疽芽孢杆菌保护性抗原大片段的嵌合流感病毒血凝素蛋白:蛋白特性、掺入感染性流感病毒以及抗原性
J Virol. 2005 Aug;79(15):10003-12. doi: 10.1128/JVI.79.15.10003-10012.2005.
2
Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.炭疽疫苗与治疗相结合:一种炭疽毒素的显性负性抑制剂也是一种高效且安全的疫苗免疫原。
Infect Immun. 2005 Jun;73(6):3408-14. doi: 10.1128/IAI.73.6.3408-3414.2005.
3
一种针对BBI39的狂犬病病毒载体疫苗的研发
Vaccines (Basel). 2024 Jan 12;12(1):78. doi: 10.3390/vaccines12010078.
4
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus.GP38作为克里米亚-刚果出血热病毒的疫苗靶点。
NPJ Vaccines. 2023 May 20;8(1):73. doi: 10.1038/s41541-023-00663-5.
5
Peptide-Based Vaccines for Tuberculosis.基于肽的结核病疫苗。
Front Immunol. 2022 Jan 31;13:830497. doi: 10.3389/fimmu.2022.830497. eCollection 2022.
6
Prophylactic vaccine delivery systems against epidemic infectious diseases.针对流行性传染病的预防性疫苗投递系统。
Adv Drug Deliv Rev. 2021 Sep;176:113867. doi: 10.1016/j.addr.2021.113867. Epub 2021 Jul 17.
7
Rhabdoviruses as vectors for vaccines and therapeutics.Rhabdoviruses 作为疫苗和治疗药物的载体。
Curr Opin Virol. 2020 Oct;44:169-182. doi: 10.1016/j.coviro.2020.09.003. Epub 2020 Oct 29.
8
Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.将 B 细胞激活因子(BAFF)整合到狂犬病病毒(RABV)颗粒的膜中可以提高疫苗诱导的抗体反应的速度和幅度。
PLoS Negl Trop Dis. 2019 Nov 14;13(11):e0007800. doi: 10.1371/journal.pntd.0007800. eCollection 2019 Nov.
9
Induction of PrP-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease.用针对慢性消耗病的口服疫苗诱导白尾鹿产生朊蛋白特异性全身和黏膜免疫反应。
Prion. 2017 Sep 3;11(5):368-380. doi: 10.1080/19336896.2017.1367083.
10
Production of Japanese Encephalitis Virus Antigens in Plants Using Bamboo Mosaic Virus-Based Vector.利用基于竹花叶病毒的载体在植物中生产日本脑炎病毒抗原
Front Microbiol. 2017 May 3;8:788. doi: 10.3389/fmicb.2017.00788. eCollection 2017.
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
用表达严重急性呼吸综合征冠状病毒(SARS-CoV)S蛋白的基于弹状病毒的载体进行单次免疫可导致产生高水平的SARS-CoV中和抗体。
J Gen Virol. 2005 May;86(Pt 5):1435-1440. doi: 10.1099/vir.0.80844-0.
4
Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.炭疽重组保护性抗原在铝佐剂存在下对小鼠的免疫原性。
Vaccine. 2005 Mar 14;23(16):1993-9. doi: 10.1016/j.vaccine.2004.10.014.
5
Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody.由表达抗保护性抗原单链抗体的腺病毒介导的炭疽毒素被动免疫疗法。
Mol Ther. 2005 Feb;11(2):237-44. doi: 10.1016/j.ymthe.2004.10.018.
6
Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.在恒河猴中对表达猿猴/人类免疫缺陷病毒SHIV89.6P包膜的糖蛋白缺陷型狂犬病病毒进行免疫原性研究。
J Virol. 2004 Dec;78(24):13455-9. doi: 10.1128/JVI.78.24.13455-13459.2004.
7
Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.将肠炎沙门氏菌伤寒血清型内源性clyA编码的溶血素用于抗原输出的改造,增强了减毒活载体疫苗株CVD 908-htrA表达的炭疽保护性抗原结构域4的免疫原性。
Infect Immun. 2004 Dec;72(12):7096-106. doi: 10.1128/IAI.72.12.7096-7106.2004.
8
Development of anthrax DNA vaccines.炭疽DNA疫苗的研发。
Curr Opin Mol Ther. 2004 Oct;6(5):506-12.
9
Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.人标准炭疽参考血清中总免疫球蛋白G及亚类的质量赋值
Clin Diagn Lab Immunol. 2004 Sep;11(5):919-23. doi: 10.1128/CDLI.11.5.919-923.2004.
10
Crystal structure of a complex between anthrax toxin and its host cell receptor.炭疽毒素与其宿主细胞受体复合物的晶体结构
Nature. 2004 Aug 19;430(7002):905-8. doi: 10.1038/nature02763. Epub 2004 Jul 4.